NOVEL 1,2-DIARYLCYCLOBUTENES : SELECTIVE AND ORALLY ACTIVE COX-2 INHIBITORS

[1]  C. Koboldt,et al.  Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. , 1996, Journal of medicinal chemistry.

[2]  J. Adams,et al.  Constitutive cyclooxygenase (COX‐1) and inducible cyclooxygenase (COX‐2): Rationale for selective inhibition and progress to date , 1996, Medicinal research reviews.

[3]  S. Boyce,et al.  Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. , 1995, The Journal of pharmacology and experimental therapeutics.

[4]  C. Koboldt,et al.  Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. , 1994, Journal of medicinal chemistry.

[5]  C. Torrance,et al.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.

[6]  B. Varnum,et al.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.

[7]  N. Ackerman,et al.  Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. , 1990, The Journal of pharmacology and experimental therapeutics.

[8]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[9]  J. Mcmurry.  Organic chemistry of low-valent titanium , 1974 .

[10]  K. Seibert,et al.  Chapter 19. Selective Cyclooxygenase Inhibitors , 1995 .

[11]  R. Danheiser,et al.  A general method for the reductive dechlorination of 4,4-dichlorocyclobutenones , 1987 .

[12]  L. Ghosez,et al.  Vicinal alkylation of alkynes. A short route toward Δα,β butenolides, furans and cyclopentenones. , 1984 .